GlobeNewswire

Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review
10/08/2026
Neurology Review Software Enhancements Included as Part of Industry-Leading Ceribell Point-of-Care Brain Monitoring System SUNNYVALE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell” [...]
Jade Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update
10/08/2026
Announced positive interim Phase 1 results for JADE101 demonstrating potential for every 12-week subcutaneous dosing and best-in-class clinical activity in IgA nephropathy Phase 2 JADE101 clinical trial in IgA [...]
Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film
10/08/2026
Human factors and clinical study results support planned resubmission of Anaphylm™ NDA in the third quarter of 2026 Self-administration pharmacokinetic (PK) results were comparable to clinician-administered PK results [...]
Tonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights
10/08/2026
TONMYA® net sales totaled approximately $11 million, an increase of 197% quarter-over-quarter Commercial and government payer coverage for TONMYA meaningfully expanded, now reaching approximately 136 million covered [...]
Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia
10/08/2026
NEW YORK and TOKYO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) ("Instinct Bio" or the "Company") today announced a cooperation agreement with PT PARVA CANDELA ("PARVA [...]
Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
10/08/2026
Total 2Q 2026 net product revenue of $218.4 million, representing 46% year-over-year growth AUVELITY ® 2Q 2026 net product sales of $180.3 million, representing 51% year-over-year growth SUNOSI ® 2Q 2026 net product [...]
ChemoMetec enters collaboration agreement with Roche Diagnostics
10/08/2026
ANNOUNCEMENT NO. 311 After entering a Letter of Intent with Roche Diagnostics in February 2026, aiming to pursue a collaboration with the goal of creating synergies between the parties’ solutions in the field of [...]
Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
10/08/2026
-- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients – -- Phase 2b PLATEAU clinical trial interim analysis and results on track for [...]
Hemp Hop THCa Dispensary Extends Pickup and Charlotte Same Day Delivery Hours to 11 PM Daily
10/08/2026
CHARLOTTE, N.C., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Hemp Hop, a THCa dispensary founded in Charlotte in 2018, has extended both dispensary pickup and Charlotte same day THCa delivery hours from 10 PM to 11 PM every day. [...]
Nanox.AI Optimizes Medical Imaging AI Application Framework for Intel Core Ultra Processors with OpenVINO
10/08/2026
On-premise medical imaging AI framework uses Intel Core Ultra processors and Intel ’s OpenVINO toolkit to accelerate edge inference within healthcare environments PETACH TIKVA, Israel – August 10 – Nanox AI Ltd. , a [...]
Life Biosciences Appoints Stephen Webster to Board of Directors
10/08/2026
Former Spark Therapeutics Chief Financial Officer brings deep biotech finance, commercialization, and governance expertise BOSTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a clinical-stage [...]
Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)
10/08/2026
JERUSALEM, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , today announced its [...]
Replimune Announces Pricing of $150 Million Underwritten Offering
10/08/2026
BOSTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL) (“Replimune”), a commercial-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the [...]
Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
10/08/2026
SAN JOSE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the company’s [...]
Telomir Announces Peer-Reviewed Publication Demonstrating Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models
10/08/2026
Iron-Rescue Experiments Confirm Iron-Dependent Mechanism. Tumor Suppressor Gene Reactivation and Anti-Tumor and Anti-Metastatic Activity Across Multiple Models. MIAMI, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Telomir [...]
Elicio Therapeutics Announces Activation of the Investigator-Initiated Phase 1 Study of Neoadjuvant ELI-002 7P for Pancreatic Ductal Adenocarcinoma
10/08/2026
Phase 1 study conducted by Memorial Sloan Kettering (“MSK”) Cancer Center and funded by The Lustgarten Foundation Study to evaluate ELI-002 7P in combination with chemotherapy and checkpoint inhibition in the [...]
Alvotech to Report Financial Results for H1 2026
10/08/2026
REYKJAVIK, ICELAND (August 10, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, [...]
Erasca Strengthens R&D Leadership with Appointment of Internationally Recognized Medical Oncologist Charles S. Fuchs, M.D., M.P.H., as President of R&D
10/08/2026
SAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/ [...]
Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader
10/08/2026
Establishes an integrated global platform spanning biosimilar R&D, manufacturing and commercialization Adds a major long-term growth pillar and extends Amneal’s growth profile into the 2030s BRIDGEWATER, N.J., Aug. [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum